诱发低丙种球蛋白血症的多发性硬化症抗 CD20（Ocrelizumab）疗法

{"title":"诱发低丙种球蛋白血症的多发性硬化症抗 CD20（Ocrelizumab）疗法","authors":"Nora Abdul-Aziz, Noor Abdulhameed, A. Marellapudi, Haroon Shah","doi":"10.46570/utjms.vol11-2023-836","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":220681,"journal":{"name":"Translation: The University of Toledo Journal of Medical Sciences","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multiple Sclerosis anti-CD20 (Ocrelizumab) therapy inducing hypogammaglobulinemia\",\"authors\":\"Nora Abdul-Aziz, Noor Abdulhameed, A. Marellapudi, Haroon Shah\",\"doi\":\"10.46570/utjms.vol11-2023-836\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":220681,\"journal\":{\"name\":\"Translation: The University of Toledo Journal of Medical Sciences\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translation: The University of Toledo Journal of Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46570/utjms.vol11-2023-836\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translation: The University of Toledo Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46570/utjms.vol11-2023-836","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}